S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

The Medicines Price Target & Analyst Ratings (NASDAQ:MDCO)

$57.57
+0.58 (+1.02 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
$56.06
Now: $57.57
$58.00
50-Day Range
$41.68
MA: $48.94
$57.30
52-Week Range
$16.69
Now: $57.57
$58.00
Volume1.91 million shs
Average Volume1.54 million shs
Market Capitalization$4.57 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.91

Analyst Ratings

The Medicines (NASDAQ:MDCO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
14 Wall Street analysts have issued ratings and price targets for The Medicines in the last 12 months. Their average twelve-month price target is $73.33, suggesting that the stock has a possible upside of 27.38%. The high price target for MDCO is $145.00 and the low price target for MDCO is $48.00. There are currently 2 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.862.923.002.88
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $73.33$72.36$64.22$54.43
Price Target Upside: 27.38% upside48.59% upside76.53% upside101.81% upside

The Medicines (NASDAQ:MDCO) Consensus Price Target History

The Medicines (NASDAQ:MDCO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/10/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$44.00 ➝ $50.00High
10/2/2019B. RileyBoost Price TargetBuy$74.00 ➝ $95.00Low
9/17/2019CitigroupDowngradeBuy ➝ Neutral$55.00Low
9/3/2019Roth CapitalSet Price TargetBuy$72.00Low
9/3/2019Leerink SwannReiterated RatingBuyLow
9/3/2019JPMorgan Chase & Co.Boost Price TargetOverweight$39.00 ➝ $49.00Medium
9/3/2019OppenheimerBoost Price TargetOutperform$52.00 ➝ $60.00High
9/2/2019Piper Jaffray CompaniesReiterated RatingOverweight ➝ Positive$142.00 ➝ $145.00High
8/26/2019Chardan CapitalSet Price TargetBuy$90.00Low
8/26/2019CowenSet Price TargetBuy$48.00Low
8/26/2019Bank of AmericaReiterated RatingBuy$51.00High
5/20/2019Robert W. BairdReiterated RatingOverweight$80.00 ➝ $110.00High
4/26/2019Goldman Sachs GroupUpgradeNeutral ➝ Buy$25.00 ➝ $55.00High
12/14/2018Wolfe ResearchInitiated CoverageOutperform ➝ OutperformLow
10/23/2017GuggenheimInitiated CoverageBuy$45.00N/A
(Data available from 10/21/2017 forward)
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: High-Yield Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel